Product details
Catalog number BNUB0195-500
Price for BNUB0195-500
Size / count 1x 500 µL
This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA) from pleural mesotheliomas (rarely or weakly CEA) . Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for CD66 (CEA) (C66/195), 0.2mg/mL is BNUB0195-500.
CD66 (CEA) (C66/195), 0.2mg/mL is available in the following size(s): 1x 500 µL.
CD66 (CEA) (C66/195), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
CD66 (CEA) (C66/195), 0.2mg/mL is manufactured by Biotium.
Estimated delivery time for CD66 (CEA) (C66/195), 0.2mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for CD66 (CEA) (C66/195), 0.2mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0295061270361e0ffd72/msds/bnub0195-500.pdf.
This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb reacts with nonspecific cross-reacting antigen (
Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.
Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.
Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.